AbCellera Biologics Inc (ABCL)

Super-investor holdings · 2026 Q2

No tracked fund reported a position in this stock in the latest 13F quarter.

All institutions · Form 13F

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Insider trading · Form 4

3 insiders bought on the open market in the last 90 days (4 purchases, $1.5M), against 0 sales by 0 insiders ($0). Latest buy: Aug 24, 2026.

Source: SEC Form 4 filings, as of Oct 3, 2026. Open-market transactions only.

Politician trading · U.S. House

Data unavailable — no House STOCK Act transactions for this ticker were parsed in the current window (as of Oct 3, 2026).

Screens & lenses

Insiders

· Insider Cluster Buying — Last 90 days: 3 or more different insiders bought on the open market

· CEO & CFO Buying — Last 90 days: top executives (CEO/CFO) bought on the open market

· Insider Net Buying — Last 90 days: more insider buy transactions than sell transactions

· Opportunistic Buys (Non-Routine) — Last 90 days: 2 or more insiders with no routine buying pattern bought on the open market

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

· 52-Week High — Recently printed a new 52-week high

· Top Relative Strength — Top 20% of the universe by 6-month return

Red Flags

· Auditor Change (8-K 4.01) — Last 2 years: an auditor change filing (8-K Item 4.01)

Key figures

· Insider Cluster Buying — Insiders buying: 3 · Buy txns: 4 · Buy value: $1.5M · Latest buy: Aug 24, 2026

· CEO & CFO Buying — Buy txns: 4 · Buy value: $1.5M · Insiders buying: 3 · Latest buy: Aug 24, 2026

· Insider Net Buying — Buy txns: 4 · Sell txns: 0 · Buy value: $1.5M · Latest buy: Aug 24, 2026

· Opportunistic Buys (Non-Routine) — Opportunistic buyers: 3 · Buy txns: 4 · Buy value: $1.5M · Latest buy: Aug 24, 2026

· Auditor Change (8-K 4.01) — Latest event: Nov 28, 2025 · Events in 2 yrs: 1

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

· Insider BEST — appeared in 4 of the last 20 quarterly lists; latest 2023 Q3, ranked #45 of 50.